Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.98 EUR
337.75 M EUR
2.26 B EUR
172.71 M
About SWEDISH ORPHAN BIOVITRUM AB
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. It operates through the Haematology, Immunology, and Specialty Care segments. The Haemotology segment focuses on haemophilia medicines Elocta and Alprolix. The immunology segment offers treatment for serious, disabling, and life-threatening diseases. The Specialty Care segment specializes in the treatment of genetic and metabolic diseases. The company was founded in 2001 and is headquartered in Solna, Sweden.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange SWEDISH ORPHAN stocks are traded under the ticker 1SOBI.
1SOBI stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in SWEDISH ORPHAN price.
We've gathered analysts' opinions on SWEDISH ORPHAN future price: according to them, 1SOBI price has a max estimate of 35.97 EUR and a min estimate of 25.31 EUR. Watch 1SOBI chart and read a more detailed SWEDISH ORPHAN stock forecast: see what analysts think of SWEDISH ORPHAN and suggest that you do with its stocks.
1SOBI stock is 0.00% volatile and has beta coefficient of 1.27. Track SWEDISH ORPHAN stock price on the chart and check out the list of the most volatile stocks — is SWEDISH ORPHAN there?
Today SWEDISH ORPHAN has the market capitalization of 9.21 B, it has decreased by −2.74% over the last week.
Yes, you can track SWEDISH ORPHAN financials in yearly and quarterly reports right on TradingView.
SWEDISH ORPHAN is going to release the next earnings report on Apr 29, 2025. Keep track of upcoming events with our Earnings Calendar.
1SOBI earnings for the last quarter are 0.35 EUR per share, whereas the estimation was 0.31 EUR resulting in a 13.32% surprise. The estimated earnings for the next quarter are 0.24 EUR per share. See more details about SWEDISH ORPHAN earnings.
SWEDISH ORPHAN revenue for the last quarter amounts to 646.47 M EUR, despite the estimated figure of 637.30 M EUR. In the next quarter, revenue is expected to reach 587.96 M EUR.
1SOBI net income for the last quarter is 121.45 M EUR, while the quarter before that showed 128.86 M EUR of net income which accounts for −5.75% change. Track more SWEDISH ORPHAN financial stats to get the full picture.
No, 1SOBI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 10, 2025, the company has 1.84 K employees. See our rating of the largest employees — is SWEDISH ORPHAN on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SWEDISH ORPHAN EBITDA is 826.87 M EUR, and current EBITDA margin is 36.53%. See more stats in SWEDISH ORPHAN financial statements.
Like other stocks, 1SOBI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SWEDISH ORPHAN stock right from TradingView charts — choose your broker and connect to your account.